Comments
Loading...

Inhibikase Therapeutics

IKTNASDAQ
Logo brought to you by Benzinga Data
$3.20
0.041.27%
At close: -
$3.27
0.072.19%
After Hours: Dec 20, 5:59 PM EDT

Inhibikase Therapeutics (NASDAQ:IKT) Stock, Dividends

Inhibikase Therapeutics issues dividends to shareholders from excess cash Inhibikase Therapeutics generates. Most companies pay dividends on a quarterly basis, but dividends may also be paid monthly, annually or at irregular intervals.

Inhibikase Therapeutics Inc Dividend Overview

Inhibikase Therapeutics Inc does not currently pay a dividend or dividend information is unavailable.

Inhibikase Therapeutics Inc's last ex-dividend date and next ex-dividend date are both unknown.

Key Highlights:

  • Annual Payout: -
  • Current Yield: -
  • Next Ex-Dividend Date: Unknown
  • Last Ex-Dividend Date: Unknown
  • Payments per Year: -

Dividends for Inhibikase Therapeutics

Data brought to you by Benzinga APIs

FAQ

Q

When does Inhibikase Therapeutics (IKT) pay its next dividend?

A

There are no upcoming dividends for Inhibikase Therapeutics.

Q

What date did I need to own Inhibikase Therapeutics (IKT) stock to get the latest dividend?

A

There are no upcoming dividends for Inhibikase Therapeutics.

Q

How much per share is the next Inhibikase Therapeutics (IKT) dividend?

A

There are no upcoming dividends for Inhibikase Therapeutics.

Q

What is the dividend yield for Inhibikase Therapeutics (NASDAQ:IKT)?

A

There are no upcoming dividends for Inhibikase Therapeutics.

Q

What was the announcement date for the next Inhibikase Therapeutics (IKT) dividend?

A

There are no upcoming dividends announced for Inhibikase Therapeutics

Q

Why is Inhibikase Therapeutics (IKT) dividend considered low?

A

There is not enough data to provide an evaluation.

Q

Is Inhibikase Therapeutics (IKT) a good dividend?

A

There is not enough data to provide an evaluation.

Q

Is the Inhibikase Therapeutics (IKT) dividend sustainable?

A

There is not enough data to provide an evaluation.

Browse Dividends on all stocks.

People Also Watch